{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "the-planning", "type": "clause", "offset": [6, 18]}], "size": 10, "samples": [{"hash": "ftTALzWezH4", "uri": "https://flsenate.gov/Session/Bill/2002/1515/BillText/Filed/PDF", "label": "flsenate.gov", "score": 18.626131493, "published": false}, {"hash": "7KMpl84wXSM", "uri": "https://www.flsenate.gov/Session/Bill/2002/261/Amendment/615153/PDF", "label": "www.flsenate.gov", "score": 18.4155966878, "published": false}, {"hash": "9t3Qt6KJSPg", "uri": "https://www.flsenate.gov/Session/Bill/2002/480/Amendment/614654/PDF", "label": "www.flsenate.gov", "score": 10.1909650924, "published": false}], "snippet": "means the planning, managing,", "hash": "807bac619a0f048c3fa0e8f75be8839d", "id": 1}, {"snippet_links": [{"key": "the-planning", "type": "clause", "offset": [6, 18]}, {"key": "adjacent-to", "type": "definition", "offset": [69, 80]}, {"key": "related-to", "type": "clause", "offset": [95, 105]}, {"key": "rail-system", "type": "clause", "offset": [144, 155]}, {"key": "pursuant-to", "type": "definition", "offset": [156, 167]}, {"key": "any-person", "type": "clause", "offset": [187, 197]}, {"key": "other-entity", "type": "clause", "offset": [256, 268]}], "size": 6, "samples": [{"hash": "fLNU90jouzc", "uri": "http://www.leg.state.fl.us/data/session/2002/house/journals/pdf/bound/jnl03-22.pdf", "label": "www.leg.state.fl.us", "score": 10.5318275154, "published": false}, {"hash": "43lEMkeNyvh", "uri": "https://www.myfloridahouse.gov/FileStores/Adhoc/Journals/data/session/2002/jnl03-22.pdf", "label": "www.myfloridahouse.gov", "score": 10.3689253936, "published": false}, {"hash": "dswe9CEWZcT", "uri": "http://laws.flrules.org/files/Ch_2013-213.pdf", "label": "laws.flrules.org", "score": 5.7289527721, "published": false}], "snippet": "means the planning, managing, financing, or constructing of projects adjacent to, functionally related to, or otherwise related to a high-speed rail system pursuant to agreements between any person, firm, corporation, association, organization, agency, or other entity, public or private.", "hash": "33bc8b8a6ec5305d8d51fe3d95e6fe1f", "id": 2}, {"snippet_links": [{"key": "technical-works", "type": "definition", "offset": [18, 33]}, {"key": "research-and-development", "type": "definition", "offset": [37, 61]}, {"key": "with-respect-to", "type": "clause", "offset": [94, 109]}, {"key": "materials-to-be", "type": "clause", "offset": [110, 125]}], "size": 5, "samples": [{"hash": "ZRyNcdl0Vz", "uri": "/contracts/ZRyNcdl0Vz#joint-development", "label": "Cooperative Development Agreement (Altus Pharmaceuticals Inc.)", "score": 21.0, "published": true}, {"hash": "fTeYD6OgWqF", "uri": "/contracts/fTeYD6OgWqF#joint-development", "label": "Cooperative Development Agreement (Altus Pharmaceuticals Inc.)", "score": 18.0, "published": true}, {"hash": "ch0w3VErmXm", "uri": "/contracts/ch0w3VErmXm#joint-development", "label": "Cooperative Development Agreement (Altus Pharmaceuticals Inc.)", "score": 18.0, "published": true}], "snippet": "means any and all technical works of research and development jointly made by ALTUS and AMANO with respect to Materials to be developed hereunder.", "hash": "cd42e5d7cdd0e9ea060773bbf50b9164", "id": 3}, {"snippet_links": [{"key": "respective-activities", "type": "definition", "offset": [10, 31]}, {"key": "of-each-party", "type": "clause", "offset": [32, 45]}, {"key": "the-activities", "type": "clause", "offset": [57, 71]}, {"key": "product-development-plan", "type": "definition", "offset": [108, 132]}], "size": 4, "samples": [{"hash": "c0RWKZymHLa", "uri": "/contracts/c0RWKZymHLa#joint-development", "label": "Collaboration Agreement (Takeda Pharmaceutical Co LTD)", "score": 32.4907597536, "published": true}, {"hash": "kIMIeXRQdkx", "uri": "/contracts/kIMIeXRQdkx#joint-development", "label": "Collaboration Agreement (Seattle Genetics Inc /Wa)", "score": 31.0971937029, "published": true}, {"hash": "fhw7KqRCOuT", "uri": "/contracts/fhw7KqRCOuT#joint-development", "label": "Collaboration Agreement (Takeda Pharmaceutical Co LTD)", "score": 29.8733744011, "published": true}], "snippet": "means the respective activities of each Party to conduct the activities that are included within the Global Product Development Plan.", "hash": "6356e6fc9b1acccd381bf82e4616e816", "id": 4}, {"snippet_links": [{"key": "the-development", "type": "clause", "offset": [6, 21]}, {"key": "applicants-for", "type": "definition", "offset": [37, 51]}, {"key": "marketing-authorisations", "type": "definition", "offset": [52, 76]}, {"key": "relating-to", "type": "definition", "offset": [77, 88]}, {"key": "medicinal-products", "type": "definition", "offset": [89, 107]}], "size": 4, "samples": [{"hash": "3eJwoHYy3nj", "uri": "https://www.legislation.gov.uk/uksi/2016/190/data.pdf", "label": "www.legislation.gov.uk", "score": 11.0479123888, "published": false}, {"hash": "aCDiW4kMo94", "uri": "https://d353ahjsg66ro4.cloudfront.net/cy/uksi/2016/190/data.pdf", "label": "d353ahjsg66ro4.cloudfront.net", "score": 10.8165639973, "published": false}, {"hash": "f1BsTqFpCNE", "uri": "https://www.legislation.gov.uk/uksi/2013/532/2013-04-01/data.pdf", "label": "www.legislation.gov.uk", "score": 10.2169746749, "published": false}], "snippet": "means the development by two or more applicants for marketing authorisations relating to medicinal products\u2014", "hash": "ee25d94bcc5b9bbf0d9c46f8283017a7", "id": 5}, {"snippet_links": [{"key": "sti-patents", "type": "definition", "offset": [62, 73]}, {"key": "trade-secret", "type": "definition", "offset": [141, 153]}, {"key": "by-sti", "type": "clause", "offset": [160, 166]}, {"key": "direct-use", "type": "definition", "offset": [221, 231]}, {"key": "sti-technology", "type": "definition", "offset": [239, 253]}, {"key": "pursuant-to", "type": "definition", "offset": [255, 266]}, {"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [271, 304]}, {"key": "patents-and-patent-applications", "type": "definition", "offset": [320, 351]}, {"key": "relating-to", "type": "definition", "offset": [364, 375]}], "size": 2, "samples": [{"hash": "lH629VmBCk3", "uri": "https://investors.eloxxpharma.com/static-files/346e7373-3f02-4202-be01-808ee76c0d4a", "label": "investors.eloxxpharma.com", "score": 9.9650924025, "published": false}, {"hash": "9wmrTEmE8ha", "uri": "https://www.sec.gov/Archives/edgar/data/1035354/000090310002000303/form10ksb_063002exh10-31.txt", "label": "Senesco Technologies Inc", "score": 2.0, "published": false}], "snippet": "means an improvement to an invention disclosed in one or more STI Patents, whether or not such improvement is patentable or protectable as a trade secret, made by STI and/or AG, which could not have been made but for the direct use of the STI Technology, pursuant to and during the term of this Agreement, including all patents and patent applications to be filed relating to any such improvement.", "hash": "3d2a4e1ef96fd1b7f264f42825473eb1", "id": 6}, {"snippet_links": [{"key": "respective-affiliates", "type": "definition", "offset": [109, 130]}, {"key": "each-case", "type": "definition", "offset": [135, 144]}, {"key": "other-third-parties", "type": "clause", "offset": [204, 223]}, {"key": "the-foregoing", "type": "definition", "offset": [274, 287]}, {"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [289, 322]}], "size": 2, "samples": [{"hash": "jzJo1ZquxZZ", "uri": "/contracts/jzJo1ZquxZZ#joint-development", "label": "Research, Option and License Agreement (BIND Therapeutics, Inc)", "score": 24.6550308008, "published": true}, {"hash": "cO7dwUGNMaG", "uri": "/contracts/cO7dwUGNMaG#joint-development", "label": "Research, Option and License Agreement (BIND Therapeutics, Inc)", "score": 24.4880219028, "published": true}], "snippet": "means any invention, development or discovery made, conceived or created jointly by BIND and Pfizer or their respective Affiliates (in each case, optionally with any (sub)licensees, subcontractors or any other Third Parties or any employees, consultants or agents of any of the foregoing) during the term of this Agreement.", "hash": "6177051fd5a79e9cde37184ee18a8736", "id": 7}, {"snippet_links": [{"key": "conduct-of", "type": "clause", "offset": [22, 32]}, {"key": "oil-and-gas-operations", "type": "clause", "offset": [33, 55]}, {"key": "with-respect-to", "type": "clause", "offset": [81, 96]}, {"key": "joint-development-area", "type": "definition", "offset": [143, 165]}], "size": 2, "samples": [{"hash": "1gVo222vHAH", "uri": "https://faolex.fao.org/docs/pdf/geo80090E.pdf", "label": "faolex.fao.org", "score": 8.9739904175, "published": false}, {"hash": "7iiShmPbZAK", "uri": "http://extwprlegs1.fao.org/docs/texts/geo80090E.doc", "label": "extwprlegs1.fao.org", "score": 8.5181382615, "published": false}], "snippet": "means the cooperative conduct of Oil and Gas Operations by two or more Operators with respect to a continuous Oil and/or Gas reservoir(s) in a Joint Development Area.", "hash": "baa9566e106466a5118e1821d9e5125c", "id": 8}, {"snippet_links": [{"key": "jointly-developed", "type": "clause", "offset": [29, 46]}, {"key": "of-each-party", "type": "clause", "offset": [79, 92]}, {"key": "during-the-term", "type": "clause", "offset": [93, 108]}, {"key": "pursuant-to", "type": "definition", "offset": [109, 120]}, {"key": "agreed-upon-terms", "type": "clause", "offset": [130, 147]}, {"key": "in-writing", "type": "definition", "offset": [170, 180]}, {"key": "by-the-parties", "type": "clause", "offset": [181, 195]}], "size": 2, "samples": [{"hash": "h89AMC16Ehj", "uri": "/contracts/h89AMC16Ehj#joint-development", "label": "E Commerce Agreement (Gsi Commerce Inc)", "score": 21.0, "published": true}, {"hash": "eYirWQNMJPH", "uri": "/contracts/eYirWQNMJPH#joint-development", "label": "E Commerce Agreement (Gsi Commerce Inc)", "score": 18.0, "published": true}], "snippet": "means any Technology that is jointly developed through the significant efforts of each Party during the Term pursuant to mutually agreed upon terms expressly agreed upon in writing by the Parties.", "hash": "63dddfd45e41a34fb35bae55621ecfac", "id": 9}, {"snippet_links": [{"key": "related-to", "type": "clause", "offset": [56, 66]}, {"key": "real-property-asset", "type": "definition", "offset": [69, 88]}, {"key": "development-projects", "type": "clause", "offset": [96, 116]}, {"key": "transit-projects", "type": "definition", "offset": [238, 254]}, {"key": "development-activities", "type": "definition", "offset": [338, 360]}, {"key": "in-lieu-of", "type": "clause", "offset": [362, 372]}, {"key": "the-agency-may", "type": "clause", "offset": [381, 395]}, {"key": "goods-and-or-services", "type": "clause", "offset": [426, 447]}, {"key": "not-limited", "type": "clause", "offset": [463, 474]}, {"key": "capital-improvements", "type": "clause", "offset": [479, 499]}, {"key": "information-services", "type": "definition", "offset": [501, 521]}, {"key": "site-maintenance", "type": "definition", "offset": [523, 539]}, {"key": "other-property-rights", "type": "clause", "offset": [544, 565]}], "size": 2, "samples": [{"hash": "ifByBG6y5tX", "uri": "https://www.bistatedev.org/wp-content/uploads/2020/11/Operations-Committee-Meeting-March-19-2021-Open-Meeting-.pdf", "label": "Notice", "score": 12.5947980835, "published": false}, {"hash": "3pzjD85flew", "uri": "https://www.bistatedev.org/wp-content/uploads/2015/07/Chapter-40-Real-Property-Economic-Development.pdf", "label": "www.bistatedev.org", "score": 8.4428473648, "published": false}], "snippet": "means an income-producing activity with a transit nexus related to a real property asset. Joint Development projects are commercial, residential, industrial, or mixed-use developments that are induced by, or enhance the effectiveness of, transit projects. Joint Development projects may include private, for-profit, as well as non-profit development activities. In lieu of income, the Agency may accept an equivalent value of goods and/or services including, but not limited to, capital improvements, information services, site maintenance, or other property rights.", "hash": "8c3afd9525f057888d177f19a11ad6dd", "id": 10}], "next_curs": "Cl4SWGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjoLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIaam9pbnQtZGV2ZWxvcG1lbnQjMDAwMDAwMGEMogECZW4YACAA", "definition": {"title": "Joint Development", "size": 65, "snippet": "means the planning, managing,", "id": "joint-development", "examples": ["The Development Program and the Development Budget will be prepared, agreed-to, and attached to the <strong>Joint Development</strong> Agreement (the \u201cAgreement\u201d).", "Alternatively, if the Parties agree, the <strong>Joint Development</strong> Committee may meet by means of teleconference, videoconference or other similar communications equipment.", "In connection with any transition of responsibilities from Acceleron to Celgene (including the transition of Manufacturing responsibility), the <strong>Joint Development</strong> Committee shall meet and discuss how best to transition such responsibilities to Celgene and, in connection with Manufacturing responsibility, shall establish a supply transition plan with respect to the applicable Licensed Product.", "Subject to the oversight of the <strong>Joint Development</strong> Committee, Celgene shall be solely responsible for managing all Celgene Development Activities relating to Licensed Compounds or Licensed Products.", "The <strong>Joint Development</strong> Committee shall meet in accordance with a schedule established by mutual written agreement of the Parties, at least once per [* * *] (and more frequently as the <strong>Joint Development</strong> Committee determines is necessary to fulfill its responsibilities), with the location for such meetings alternating between Acceleron\u2019s facilities and Celgene\u2019s facilities (or such other locations as are determined by the <strong>Joint Development</strong> Committee).", "Unless otherwise agreed by the Parties, the <strong>Joint Development</strong> Committee shall be comprised of three (3) representatives from each Party with one (1) representative with relevant decision-making authority from each Party such that the <strong>Joint Development</strong> Committee is able to effectuate all of its decisions within the scope of its responsibilities as set forth in Section 3.1.5 below.", "Each such subcommittee and project team shall report recommendations and proposed actions to the <strong>Joint Development</strong> Committee or Joint Commercialization Committee, as applicable, which shall approve or reject such recommendations or actions proposed in accordance with the terms of this Agreement.", "Upon mutual agreement of the Parties, additional representatives or consultants may be invited to attend a <strong>Joint Development</strong> Committee meeting, subject to such representatives\u2019 and consultants\u2019 written agreement to comply with the requirements of Article 9.", "Upon Celgene\u2019s exercise of an Option, the initial Development Plan/Budget proposed by Acceleron (including the proposed Initial Development Diseases), with such changes as are determined by Celgene, in its sole discretion, shall be deemed part of the Development Plan/Budget and deemed approved by the <strong>Joint Development</strong> Committee.", "In advance of the formation of the <strong>Joint Development</strong> Committee, either Party may request that the Parties, and the other Party agrees that they shall, meet (in person or by teleconference) for the purposes of facilitating the performance by each Party of its activities hereunder."], "related": [["joint-development-agreement", "Joint Development Agreement", "<strong>Joint Development</strong> Agreement"], ["infill-development", "Infill development", "Infill development"], ["joint-development-committee", "Joint Development Committee", "<strong>Joint Development</strong> Committee"], ["development", "Development", "Development"], ["economic-development", "Economic development", "Economic development"]], "related_snippets": [], "updated": "2025-07-06T21:58:41+00:00"}, "json": true, "cursor": ""}}